Development and field evaluation in African and Asian countries of an hepatitis B virus PCR on open polyvalent platforms to determine treatment eligibility: results from the "Agence Nationale de Recherche sur le Sida et les hépatites" 12327 study.
Dramane KaniaJanin NouhinKarine BolloréRichard NjouomThomas d'Aquin ToniAlmoustapha Issiaka MaigaCoumba Toure-KaneNicole Ngo-Giang-HuongAnoumou DagnraDuy Hoang Chuong LeFrançoise Lunel-FabianiJoany Castera-GuyPierre-Alain RubboAmandine PisoniJean-Christophe PlantierEdouard TuaillonPublished in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (2024)
This field evaluation showed that our HBV PCR test is a valuable alternative to proprietary PCR systems. PCR assays on open platforms contribute to expanding clinical laboratory solutions for diagnosing individuals who meet the viral load criteria for antiviral therapy (>20 000 IU/mL) and mother-to-child prophylaxis (>200 000 IU/mL).